Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Has results × Advanced Cancer × Clear all

Phase

Phase 1 8 Phase 2 5 Phase 1/2 3 Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 241 Carcinoma, Non-Small-Cell Lung 169 Prostatic Neoplasms 126 Neoplasms 125 Multiple Myeloma 99 Neoplasm Metastasis 73 Colorectal Neoplasms 69 Leukemia, Myeloid, Acute 63 Parkinson Disease 4, Autosomal Dominant Lewy Body 56 Lung Neoplasms 56 Melanoma 55 Lymphoma, Follicular 53 Lymphoma, Non-Hodgkin 52 Leukemia, Lymphocytic, Chronic, B-Cell 52 Papillomavirus Infections 49 Precursor Cell Lymphoblastic Leukemia-Lymphoma 45 Leukemia 45 Lymphoma 43 Carcinoma, Renal Cell 42 Ovarian Neoplasms 41 Uterine Cervical Neoplasms 40 Keratosis, Actinic 39 Carcinoma, Hepatocellular 39 Recurrence 36 Pain 36 Urinary Bladder Neoplasms 29 Pancreatic Neoplasms 29 Head and Neck Neoplasms 29 Fallopian Tube Neoplasms 29 Stomach Neoplasms 28

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02743494 2025-11-18

CheckMate 577

Bristol-Myers Squibb

Phase 3 Completed

794 enrolled 13 charts 1 FDA

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡